Rathbones Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $318K | Sell |
|
|||||
2025
Q1 | $375K | Sell |
|
|||||
2024
Q4 | $314K | Buy |
|
|||||
2024
Q3 | $274K | Hold |
|
|||||
2024
Q2 | $224K | Sell |
|
|||||
2024
Q1 | $270K | Sell |
|
|||||
2023
Q4 | $339K | Buy |
|
|||||
2023
Q3 | $302K | Buy |
|
|||||
2022
Q3 | – | Sell |
|
|||||
2022
Q2 | $270K | Sell |
|
|||||
2022
Q1 | $322K | Hold |
|
|||||
2021
Q4 | $394K | Sell |
|
|||||
2021
Q3 | $438K | Sell |
|
|||||
2021
Q2 | $613K | Buy |
|
|||||
2021
Q1 | $567K | Sell |
|
|||||
2020
Q4 | $566K | Sell |
|
|||||
2020
Q3 | $623K | Hold |
|
|||||
2020
Q2 | $758K | Buy |
|
|||||
2020
Q1 | $662K | Buy |
|
|||||
2019
Q4 | $448K | Sell |
|
|||||
2019
Q3 | $459K | Buy |
|
|||||
2019
Q2 | $410K | Buy |
|
|||||
2019
Q1 | $361K | Buy |
|
|||||
2018
Q4 | $337K | Sell |
|
|||||
2018
Q3 | $1.1M | Sell |
|
|||||
2018
Q2 | $1.02M | Buy |
|
|||||
2018
Q1 | $1.08M | Buy |
|
|||||
2017
Q4 | $1.01M | Sell |
|
|||||
2017
Q3 | $1.15M | Buy |
|
|||||
2017
Q2 | $1M | Buy |
|
|||||
2017
Q1 | $506K | Sell |
|
|||||
2016
Q4 | $1.37M | Buy |
|
|||||
2016
Q3 | $1.48M | Sell |
|
|||||
2016
Q2 | $1.65M | Buy |
|
|||||
2016
Q1 | $1.5M | Sell |
|
|||||
2015
Q4 | $14.4M | Buy |
|
|||||
2015
Q3 | $15.1M | Buy |
|
|||||
2015
Q2 | $17.5M | Sell |
|
|||||
2015
Q1 | $14.9M | Sell |
|
|||||
2014
Q4 | $14.3M | Buy |
|
|||||
2014
Q3 | $16.2M | Buy |
|
|||||
2014
Q2 | $877K | Buy |
|
|||||
2014
Q1 | $705K | Buy |
|
|||||
2013
Q4 | – | Sell |
|
|||||
2013
Q3 | $651K | Hold |
|
|||||
2013
Q2 | $531K | Buy |
|